HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Nasopharyngeal Cancer

Nasopharyngeal cancer is a rare type of head and neck cancer that originates in the nasopharynx, the upper part of the throat behind the nose. This particular form of cancer is distinct in its occurrence, as it is more prevalent in certain geographic regions, including parts of Asia and North Africa. The primary cause of nasopharyngeal cancer is linked to the Epstein-Barr virus (EBV), although other risk factors such as genetic predisposition, consumption of preserved foods containing nitrosamines, Symptoms of nasopharyngeal cancer can be subtle in the early stages, often resembling common respiratory issues. These may include nasal congestion, a persistent sore throat, earaches, and recurrent nosebleeds. As the cancer progresses, more noticeable symptoms may manifest, such as a lump in the neck, difficulty hearing, and changes in voice. Diagnosis typically involves a combination of imaging tests, such as MRI and CT scans, along with a biopsy to confirm the presence of cancer cells. Treatment options vary depending on the stage of the cancer but may include a combination of surgery, radiation therapy, and chemotherapy. Prognosis for nasopharyngeal cancer is influenced by factors like the stage at which it is diagnosed and the patient's overall health.the location of the tumor and its proximity to critical structures in the head and neck can pose challenges in managing and treating this type of cancer. Regular medical check-ups, particularly for individuals in high-risk regions or with a family history of nasopharyngeal cancer, can aid in early detection and prompt intervention. Awareness of potential symptoms and risk factors is crucial for seeking timely medical attention and improving the chances of successful treatment.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp